469 related articles for article (PubMed ID: 21401807)
21. Vascular normalization: a real benefit?
Ribatti D
Cancer Chemother Pharmacol; 2011 Aug; 68(2):275-8. PubMed ID: 21638121
[TBL] [Abstract][Full Text] [Related]
22. [Angiogenic inhibitors and radiotherapy: from the concept to the clinical trial].
Cohen-Jonathan Moyal E
Cancer Radiother; 2009 Oct; 13(6-7):562-7. PubMed ID: 19695923
[TBL] [Abstract][Full Text] [Related]
23. Targeted therapies of cancer: angiogenesis inhibition seems not enough.
Roodink I; Leenders WP
Cancer Lett; 2010 Dec; 299(1):1-10. PubMed ID: 20889254
[TBL] [Abstract][Full Text] [Related]
24. [Anti-angiogenic drugs].
Sato Y
Nihon Rinsho; 2010 Oct; 68(10):1825-9. PubMed ID: 20954324
[TBL] [Abstract][Full Text] [Related]
25. [Angiogenesis and radiotherapy (vessels, anaemia, oxygen and radiosensitivity)].
Lartigau E
Bull Cancer; 2007 Jul; 94 Spec No():S197-202. PubMed ID: 17846005
[TBL] [Abstract][Full Text] [Related]
26. Tumor angiogenesis and vascular normalization: alternative therapeutic targets.
Viallard C; Larrivée B
Angiogenesis; 2017 Nov; 20(4):409-426. PubMed ID: 28660302
[TBL] [Abstract][Full Text] [Related]
27. Platelets and cancer: implications for antiangiogenic therapy.
Trikha M; Nakada MT
Semin Thromb Hemost; 2002 Feb; 28(1):39-44. PubMed ID: 11885024
[TBL] [Abstract][Full Text] [Related]
28. VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenic.
Epstein RJ
Cancer Metastasis Rev; 2007 Dec; 26(3-4):443-52. PubMed ID: 17786538
[TBL] [Abstract][Full Text] [Related]
29. The interaction of radiation therapy and antiangiogenic therapy.
O'Reilly MS
Cancer J; 2008; 14(4):207-13. PubMed ID: 18677126
[TBL] [Abstract][Full Text] [Related]
30. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
31. Anti-angiogenic therapies in cancer: achievements and open questions.
Ruegg C; Mutter N
Bull Cancer; 2007 Sep; 94(9):753-62. PubMed ID: 17878094
[TBL] [Abstract][Full Text] [Related]
32. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
Wachsberger P; Burd R; Dicker AP
Clin Cancer Res; 2003 Jun; 9(6):1957-71. PubMed ID: 12796357
[TBL] [Abstract][Full Text] [Related]
33. Pericytes and vessel maturation during tumor angiogenesis and metastasis.
Raza A; Franklin MJ; Dudek AZ
Am J Hematol; 2010 Aug; 85(8):593-8. PubMed ID: 20540157
[TBL] [Abstract][Full Text] [Related]
34. Use of angiogenesis inhibitors in tumour treatment.
Fayette J; Soria JC; Armand JP
Eur J Cancer; 2005 May; 41(8):1109-16. PubMed ID: 15911233
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia: a key regulator of angiogenesis in cancer.
Liao D; Johnson RS
Cancer Metastasis Rev; 2007 Jun; 26(2):281-90. PubMed ID: 17603752
[TBL] [Abstract][Full Text] [Related]
36. Novel alternatives for anti-angiogenetic therapy and therapeutic angiogenesis.
Mazzone M
Verh K Acad Geneeskd Belg; 2010; 72(3-4):165-75. PubMed ID: 21067068
[TBL] [Abstract][Full Text] [Related]
37. Pericytes: a double-edged sword in cancer therapy.
Meng MB; Zaorsky NG; Deng L; Wang HH; Chao J; Zhao LJ; Yuan ZY; Ping W
Future Oncol; 2015; 11(1):169-79. PubMed ID: 25143028
[TBL] [Abstract][Full Text] [Related]
38. Regulation of tumor angiogenesis by dietary fatty acids and eicosanoids.
Rose DP; Connolly JM
Nutr Cancer; 2000; 37(2):119-27. PubMed ID: 11142082
[TBL] [Abstract][Full Text] [Related]
39. Escape mechanisms after antiangiogenic treatment, or why are the tumors growing again?
Hlushchuk R; Makanya AN; Djonov V
Int J Dev Biol; 2011; 55(4-5):563-7. PubMed ID: 21858777
[TBL] [Abstract][Full Text] [Related]
40. The multifaceted activity of VEGF in angiogenesis - Implications for therapy responses.
Moens S; Goveia J; Stapor PC; Cantelmo AR; Carmeliet P
Cytokine Growth Factor Rev; 2014 Aug; 25(4):473-82. PubMed ID: 25169850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]